https://neurodex.co/neurodex-award-from-mjff/2025-12-11T06:24:23+00:00https://neurodex.co/neurodex-presents-friends-and-foes-ii-congress/2026-11-03T18:36:36+00:00https://neurodex.co/neurodex-award-addf/2026-11-03T18:35:23+00:00https://neurodex.co/michael-j-fox-foundation-funds-research-on-a-potential-parkinsons-biomarker/2026-11-03T18:43:30+00:00https://neurodex.co/fda-advisory-committee-supports-biogen-and-eisais-alzheimers-drug-leqembi/2026-11-03T18:35:20+00:00https://neurodex.co/roche-receives-fda-alzheimers/2025-08-27T19:56:31+00:00https://neurodex.co/lexingtons-cyteir-therapeutics-to-close/2023-07-02T13:53:52+00:00https://neurodex.co/revolutionizing-antibody-design-harnessing-the-power-of-generative-ai/2025-08-27T19:54:46+00:00https://neurodex.co/roche-launches-legal-battle-against-biogens-imitative-biosimilar-of-blockbuster-arthritis-drug/2025-08-27T20:24:06+00:00https://neurodex.co/donanemab-shows-promising-results-in-slowing-cognitive-decline-in-alzheimers-disease/2025-08-27T19:53:28+00:00https://neurodex.co/sunbird-bio-and-glympse-bio-merge-to-accelerate-development-of-innovative-protein-based-diagnostic-technologies/2026-11-03T18:35:18+00:00https://neurodex.co/cervomeds-merger-with-eip-pharma-paving-the-way-for-brain-disease-treatments/2026-11-03T18:35:17+00:00https://neurodex.co/nimbus-therapeutics-secures-210-million-investment-from-gv-googles-investment-arm-for-ai-driven-drug-discovery/2023-09-08T14:51:19+00:00https://neurodex.co/groundbreaking-canadian-ai-technology-revolutionizes-early-detection-of-als/2026-11-03T18:35:15+00:00https://neurodex.co/neurodexs-chief-scientific-officer-dr-erez-eitan-to-speak-on-groundbreaking-biomarker-research-at-isev-workshop/2025-08-28T21:04:57+00:00https://neurodex.co/neurodex-to-participate-in-2nd-annual-aaev-meeting-exploring-the-potential-of-extracellular-vesicles/2026-11-03T18:43:28+00:00https://neurodex.co/neurodex-announces-second-award-from-the-michael-j-fox-foundation/2025-08-27T19:34:21+00:00https://neurodex.co/promising-results-from-athira-pharmas-fosgonimeton/2026-11-03T18:43:26+00:00https://neurodex.co/exosomes-the-unseen-players-in-neurodegenerative-diseases/2026-11-03T18:35:13+00:00https://neurodex.co/china-approves-leqembi/2025-08-27T19:29:16+00:00https://neurodex.co/neurodegenerative-disease-market/2026-11-03T18:43:26+00:00https://neurodex.co/neurodex-at-the-bio-neuroscience-conference/2025-08-27T19:26:06+00:00https://neurodex.co/revolutionary-3d-printed-brain-tissue-offers-new-insights-into-neuroscience/2026-07-28T22:51:02+00:00https://neurodex.co/the-battle-against-parkinsons-disease/2026-11-03T18:35:11+00:00https://neurodex.co/biomarkers-in-neurodegenerative-disease-diagnostics/2026-11-03T18:43:25+00:00https://neurodex.co/alzheimers-association-international-conference-aaic-2024/2026-01-21T21:21:02+00:00https://neurodex.co/biomarker-discovery-services/2026-01-21T21:14:01+00:00https://neurodex.co/neurodex-awarded-target-als/2026-01-21T21:12:41+00:00https://neurodex.co/transforming-detection-neurodexs-innovative-biomarker/2026-01-21T21:02:03+00:00https://neurodex.co/lewy-body-dementia/2026-11-03T19:43:04+00:00https://neurodex.co/exosomes/2026-11-03T19:12:55+00:00https://neurodex.co/biomarkers/2026-11-03T19:45:34+00:00https://neurodex.co/neurodegenerative-diseases-overview/2026-11-03T19:43:43+00:00https://neurodex.co/understanding-parkinsons-disease-symptoms-causes-and-treatment/2026-11-03T19:42:55+00:00https://neurodex.co/alzheimers-disease/2026-11-03T19:42:56+00:00https://neurodex.co/dr-erez-eitan-at-alzheimers-association-conference/2025-12-30T18:17:19+00:00https://neurodex.co/exploring-als-treatment-options/2026-11-03T18:43:22+00:00https://neurodex.co/role-of-biomarkers-in-als-diagnosis-and-monitoring/2026-11-03T18:43:22+00:00https://neurodex.co/als-drug-development-comparing-competing-modalities/2026-11-03T18:43:22+00:00https://neurodex.co/tdp-43-in-als-and-neurodegeneration/2026-11-03T18:47:44+00:00https://neurodex.co/dr-eitan-to-participate-in-mds/2026-11-03T19:45:33+00:00https://neurodex.co/understanding-biomarker-analysis-in-medicine/2026-11-03T20:18:01+00:00https://neurodex.co/latest-advances-in-parkinsons-clinical-trials/2026-11-03T20:16:52+00:00https://neurodex.co/alpha-synuclein-seed-amplification-assays/2025-11-20T18:33:04+00:00https://neurodex.co/neurodex-2025-advancing-als-biomarker-discovery/2026-11-03T18:43:20+00:00https://neurodex.co/huntingtons-disease-biomarker-discoveries-treatments/2026-01-04T03:37:39+00:00https://neurodex.co/10-kinds-of-dementia/2026-11-03T19:42:58+00:00https://neurodex.co/next-generation-biomarkers-for-neurodegeneration/2026-01-15T17:51:06+00:00https://neurodex.co/amyotrophic-lateral-sclerosis-als/2026-11-03T19:42:59+00:00https://neurodex.co/neurodex-contributes-to-landmark-review-on-tissue-specific-extracellular-vesicles-and-the-future-of-liquid-biopsy/2026-02-03T18:45:36+00:00https://neurodex.co/neurodex-powers-new-neuron-ev-rna-seq-dataset-in-amp-pdrd/2026-11-03T19:45:30+00:00https://neurodex.co/nf-%ce%bab-unraveling/2026-11-03T19:12:56+00:00https://neurodex.co/liquid-biopsy-for-neurodegenerative-diseases/2026-02-23T03:26:25+00:00https://neurodex.co/irs1-in-blood/2026-02-23T04:08:22+00:00https://neurodex.co/frontotemporal-dementia/2026-11-03T19:43:00+00:00https://neurodex.co/huntingtons-disease/2026-11-03T19:12:48+00:00https://neurodex.co/multiple-system-atrophy/2026-11-03T19:43:02+00:00https://neurodex.co/extracellular-vesicles-in-neuroscience/2026-03-10T19:57:46+00:00https://neurodex.co/neurodex-to-present-adpd2026/2026-03-11T18:49:15+00:00https://neurodex.co/alpha-synuclein-biomarkers-for-parkinsons-disease-and-lewy-body-dementia-from-brain-pathology-to-blood-test/2026-11-03T18:43:17+00:00https://neurodex.co/tau-and-ptau-biomarkers-in-alzheimers-disease/2026-11-03T19:12:33+00:00https://neurodex.co/liquid-biopsy-for-neurological-diseases-how-it-works/2026-03-13T15:59:14+00:00https://neurodex.co/how-extracellular-vesicles-carry-biomarkers/2026-03-26T19:30:44+00:00https://neurodex.co/alpha-synuclein-biomarkers-for-parkinsons-disease/2026-11-03T19:44:57+00:00https://neurodex.co/parkinsons-disease-clinical-trials-in-2026/2026-06-17T17:50:17+00:00https://neurodex.co/neurodex-stanford-cns-target-glp-1-agents/2026-04-22T18:17:06+00:00https://neurodex.co/csf-the-case-for-blood-based-cns-biomarkers/2026-11-03T18:43:17+00:00https://neurodex.co/blood-biomarkers-for-rare-neurological-diseases/2026-11-03T19:43:40+00:00https://neurodex.co/ella-neurofilament-light-chain-nf-l-immunoassay/2026-05-16T21:14:02+00:00https://neurodex.co/the-tdp-43-decade-has-begun/2026-06-17T19:25:56+00:00https://neurodex.co/ella-glial-fibrillary-acidic-protein-gfapimmunoassay/2026-06-25T04:36:52+00:00https://neurodex.co/a-2026-guide-to-the-als-clinical-trials-landscape/2026-09-24T16:37:15+00:00https://neurodex.co/why-csf-biomarkers-break-down-in-late-stage-cns-trials/2026-06-18T16:28:07+00:00https://neurodex.co/your-end-to-end-partner-for-the-isolation-and-profiling-of-neuron-derived-extracellular-vesicles-ndevs/2026-11-03T18:43:15+00:00https://neurodex.co/brain-specific-biomarkers-in-blood/2026-11-03T18:43:15+00:00https://neurodex.co/nfl-has-earned-its-place-in-cns-trials/2026-06-26T17:11:44+00:00https://neurodex.co/ella-phosphorylated-tau-217-p-tau217-immunoassay/2026-06-29T15:39:33+00:00https://neurodex.co/why-nde-based-biomarkers/2026-11-03T18:43:13+00:00https://neurodex.co/neurodex-exosort-platform-als/2026-07-01T18:39:43+00:00https://neurodex.co/tdp-43-measurement-als-blood-biomarker/2026-11-03T18:35:04+00:00https://neurodex.co/tdp-43-proteinopathy/2026-11-03T19:43:42+00:00https://neurodex.co/tissue-specific-extracellular-vesicles/2026-07-14T19:45:05+00:00https://neurodex.co/alpha-synuclein-works-its-not-trial-ready-yet/2026-07-16T13:59:56+00:00https://neurodex.co/what-is-a-blood-test-for-alzheimers/2026-11-03T19:43:37+00:00https://neurodex.co/tdp-43-in-blood-proving-target-engagement/2026-11-03T18:43:13+00:00https://neurodex.co/tdp-43-high-enrichment-for-als-trials/2026-07-30T15:42:20+00:00https://neurodex.co/what-to-demand-from-a-cns-biomarker-service-provider/2026-08-18T16:55:58+00:00https://neurodex.co/csf-imaging-miss-alpha-synuclein-target-engagement/2026-08-06T14:58:00+00:00https://neurodex.co/measuring-cns-target-engagement-without-a-spinal-tap/2026-08-18T16:54:28+00:00https://neurodex.co/alzheimers-blood-biomarker-discovery-for-drug-programs/2026-08-18T16:51:27+00:00https://neurodex.co/how-to-select-blood-biomarkers-for-a-parkinsons-trial/2026-08-18T17:21:01+00:00https://neurodex.co/add-a-brain-specific-biomarker-to-a-trial-panel/2026-08-25T13:24:59+00:00https://neurodex.co/lewy-body-dementia-building-a-blood-biomarker-strategy/2026-11-03T18:43:11+00:00https://neurodex.co/companion-diagnostic-development-blood-cns-biomarker/2026-08-31T18:36:53+00:00https://neurodex.co/als-biomarker-clinical-trial-endpoint/2026-09-03T20:13:43+00:00https://neurodex.co/alzheimers-tau-biomarker-testing-partner/2026-11-03T18:35:01+00:00https://neurodex.co/blood-based-cns-biomarkers-improve-cns-trial-endpoints/2026-09-16T14:31:23+00:00https://neurodex.co/alzheimers-blood-biomarker-clinical-development/2026-09-17T17:30:27+00:00https://neurodex.co/alzheimers-blood-biomarkers-diagnostic-gap/2026-11-03T18:08:22+00:00https://neurodex.co/blood-biomarker-variability-longitudinal-trial-design/2026-09-23T14:39:06+00:00https://neurodex.co/where-ai-is-actually-working-in-neuroscience/2026-11-03T18:43:10+00:00https://neurodex.co/late-and-mixed-pathology-separating-signals/2026-09-28T18:48:37+00:00https://neurodex.co/companion-diagnostic-blood-based-cns-biomarkers/2026-09-30T16:57:37+00:00https://neurodex.co/mulit-site-cns-biomarker-study/2026-11-03T18:43:10+00:00https://neurodex.co/erez-eitan-at-2026-parkinsons-disease-conference/2026-10-07T14:24:23+00:00https://neurodex.co/test-a-blood-biomarker-on-samples-you-already-have/2026-10-07T15:26:16+00:00https://neurodex.co/alpha-synuclein-blood-biomarker-lewy-body-autopsy/2026-10-08T18:09:24+00:00https://neurodex.co/preclinical-cns-biomarker-human-blood/2026-10-14T16:21:43+00:00https://neurodex.co/alpha-synuclein-parkinsons-stratification/2026-10-20T14:43:30+00:00https://neurodex.co/alpha-synuclein-blood-test-prodromal-parkinsons/2026-10-22T15:36:59+00:00https://neurodex.co/glp-1-cns-target-engagement-blood-biomarkers/2026-11-02T19:40:47+00:00https://neurodex.co/plasma-p-tau-specificity-als-alzheimers-trials/2026-10-27T18:06:12+00:00https://neurodex.co/parkinsons-disease-blood-biomarker-trial-enrollment/2026-10-28T19:31:45+00:00https://neurodex.co/nfl-vs-neuron-derived-exosome-biomarkers/2026-11-03T21:43:51+00:00https://neurodex.co/isolation-of-neuron-derived-vesicles-l1cam-debate/2026-11-03T17:54:38+00:00https://neurodex.co/what-are-neuron-derived-extracellular-vesicles/2026-11-03T21:33:44+00:00https://neurodex.co/types-of-biomarkers-explained/2026-11-03T21:30:43+00:00https://neurodex.co/cns-biomarker-glossary/2026-11-03T21:40:19+00:00https://neurodex.co/clia-vs-glp-vs-gclp/2026-11-03T21:53:44+00:00https://neurodex.co/blood-vs-csf-vs-pet-biomarkers/2026-11-03T21:57:59+00:00